Prevalence of anti-hepatitis E virus IgG antibodies in sera from hemodialysis patients in Tripoli, Lebanon.
Mohamad Bachar IsmailImad Al KassaaDima El SafadiSarah Al OmariHassan MallatFouad DabboussiMounzer HamzePublished in: PloS one (2020)
Hepatitis E virus (HEV) is an important global public health concern. Several studies reported a higher HEV prevalence in patients undergoing regular hemodialysis (HD). In Lebanon, the epidemiology of HEV among HD patients has never been investigated previously. In this study, we examine the seroprevalence of HEV infection among 171 HD patients recruited from three hospital dialysis units in Tripoli, North Lebanon. Prevalence of anti-HEV IgG antibodies was evaluated in participant's sera using a commercial enzyme-linked immunosorbent assay (ELISA). The association of socio-demographic and clinical parameters with HEV infection in patients was also evaluated. Overall, 96 women and 75 men were enrolled in this study. Anti-HEV IgG antibodies were found positive in 37/171 HD patients showing a positivity rate of 21.63%. Among all examined variables, only the age of patients was significantly associated with seropositivity (P = 0.001). This first epidemiological study reveals a high seroprevalence of HEV infection among Lebanese HD patients. However, further evaluations that enroll larger samples and include control groups are required to identify exact causative factors of the important seropositivity rate in this population.
Keyphrases
- end stage renal disease
- chronic kidney disease
- public health
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- healthcare
- patients undergoing
- risk factors
- emergency department
- type diabetes
- pregnant women
- metabolic syndrome
- high resolution
- adipose tissue
- polycystic ovary syndrome
- electronic health record
- adverse drug